| Literature DB >> 30845637 |
Søren D Nielsen1, Stig Purup2, Lotte B Larsen3.
Abstract
Potential beneficial effects of bioactive peptides derived from casein on epithelial cellular wound healing in the gastrointestinal tract were studied. Bovine casein was digested by a combination of pepsin and pancreatic proteases at different time intervals to represent ranges of duration of gastrointestinal digestion. Intestinal epithelial cells were used as an in vitro model of the small intestine. The effect of casein hydrolysates on cell migration was studied by scratch assay as a model of wound healing. Casein digested by pepsin and pancreatin for 10 to 30 min were found to have a significant stimulatory effect of >40% on cell migration relative to the control. A potential effect of casein gastrointestinal digests on gastro-intestinal wound healing has not previously been reported. The peptide profiles of active as well as inactive casein hydrolysates were characterised by liquid chromatography coupled to ion trap tandem mass spectrometry. By comparison of identified peptides in active and inactive casein hydrolysates, a pool of 11 peptides derived from casein were identified as potential candidates for effects on cell migration. Searching the milk bioactive peptide database (MBPDB) showed that 15 of the identified peptides had known biological functions such as antimicrobial, antioxidant, and immunomodulatory activity.Entities:
Keywords: IEC-6 cells; bioactive; dairy; functional foods; peptide; scratch assay; wound healing
Year: 2019 PMID: 30845637 PMCID: PMC6462906 DOI: 10.3390/foods8030091
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1Tris-Tricine SDS-PAGE of casein hydrolysates. Casein was hydrolyzed at 37 °C for 1 h with pepsin followed by the addition of corolase. Lane 1: Molecular mass marker; lanes 2–4: Control casein incubated at 37 °C at pH 2.5 for 1 h followed by pH adjusted to 7.4 and subsequently incubated for 0, 60, or 120 min, respectively; lanes 5–9: casein incubated at 37 °C at pH 2.5 with pepsin for 1 h, followed by addition of corolase at pH 7.4 and incubated for t = 0, 10, 30, 60, 120 min, respectively. The gel was stained with Coomassie Brilliant Blue G-250. The positions of αs1 dimer, αs2 monomer, and αs1, β + κ monomers are shown on the gel.
Figure 2Free amino terminal determination of casein incubated at 37 °C at pH 2.5 with pepsin for 1 h, followed by addition of corolase at pH 7.4 and incubated for t = 0, 10, 30, 60, 120 min, respectively.
The effect of 10 K and 3 K filtrates of casein hydrolysates on cell migration (n = 24).
| Casein Hydrolysate a | |||||
|---|---|---|---|---|---|
| Time Point (min) | 0.0% | 0.1% | 1.0% | 2.5% | |
| 10 K | 0 | 1.00 ± 0.13 | 1.20 ± 0.13 | 1.12 ± 0.13 | 1.01 ± 0.14 |
| 10 b | 1.00 ± 0.16 | 1.42 ± 0.15 ** | 1.36 ± 0.15 * | 1.45 ± 0.17 ** | |
| 30 b | 1.00 ± 0.20 | 1.36 ± 0.18 * | 1.55 ± 0.17 ** | 1.15 ± 0.17 | |
| 60 | 1.00 ± 0.14 | 0.91 ± 0.14 | 1.13 ± 0.13 | 0.96 ± 0.14 | |
| 120 | 1.00 ± 0.12 | 1.18 ± 0.12 | 1.10 ± 0.12 | 0.77 ± 0.18 | |
| 3 K | 0 | 1.00 ± 0.13 | 1.01 ± 0.14 | 0.97 ± 0.15 | 0.98 ± 0.13 |
| 10 b | 1.00 ± 0.12 | 1.08 ± 0.10 | 1.09 ± 0.12 | 1.09 ± 0.12 | |
| 30 b | 1.00 ± 0.10 | 1.14 ± 0.10 | 1.22 ± 0.10 ** | 1.05 ± 0.10 | |
| 60 | 1.00 ± 0.14 | 1.19 ± 0.15 | 1.23 ± 0.05 | 1.13 ± 0.19 | |
| 120 | 1.00 ± 0.11 | 1.10 ± 0.11 | 1.00 ± 0.1 | 0.94 ± 0.10 | |
a Values are presented as relative to cell migration obtained in basal medium without any addition of casein hydrolysates (BM = 1.00) and given as means ± SEM. * p < 0.05, ** p < 0.01. b The peptide profile of these samples was further investigated by LC-ESI/MS/MS.
Peptides identified as potential candidates for intestinal cell migration activity due to their differential presence in active and non-active casein hydrolysates as determined by LC-ESI/MS/MS.
| Protein | Mass [M + H]+ | Peptide Sequence |
|---|---|---|
| αs1-casein (148–158) | 1200.6 | EPMIGVNQELA |
| αs1-casein (189–208) | 2105.0 | TDAPSFSDIPNPIGSENSEK |
| β-casein (139–154) | 1775.0 | SLTLTDVENLHLPLPL |
| β-casein (158–171) | 1698.8 | WMHQPHQPLPPTVM |
| β-casein (158–177) | 2354.2 | WMHQPHQPLPPTVMFPPQSV |
| β-casein (158–178) | 2467.2 | WMHQPHQPLPPTVMFPPQSVL |
| β-casein (160–171) | 1381.7 | HQPHQPLPPTVM |
| β-casein (84–108) | 2741.5 | SLPQNIPPLTQTPVVVPPFLQPEVM |
| β-casein (96–107) | 1320.8 | PVVVPPFLQPEV |
| κ-casein (134–145) | 1373.7 | NQDKTEIPTINT |
| κ-casein (70–81) | 1452.8 | ALINNQFLPYPY |
Bioactive peptides identfied in casein hydrolysates by searching the milk bioactive peptide database (MBPDB).
| Protein | Sequence | Function |
|---|---|---|
| αs1-casein (39–48) | FVAPFPEVFG | ACE-inhibitory a |
| αs1-casein (119–124) | YKVPQL | ACE-inhibitory |
| αs1-casein (195–208) | SDIPNPIGSENSEK | Antimicrobial |
| αs2-casein (96–104) | ALNEINQFY | ACE-inhibitory |
| αs2-casein (204–212) | AMKPWIQPK | ACE-inhibitory |
| β-casein (74–83) | VYPFPGPIPN | ACE-inhibitory, antioxidant |
| β-casein (113–120) | VKEAMAPK | Antimicrobial, antioxidant |
| β-casein (115–120) | EAMAPK | Antimicrobial |
| β-casein (121–128) | HKEMPFPK | Antimicrobial |
| β-casein (185–191) | VLPVPQK | Antimicrobial, ACE-inhibitory, antioxidant |
| β-casein (208–224) | YQEPVLGPVRGPFPIIV | ACE-inhibitory, immunoregulatory |
| β-casein (209–224) | QEPVLGPVRGPFPIIV | ACE-inhibitory |
| β-casein (208–222) | YQEPVLGPVRGPFPI | Antimicrobial |
| κ-casein (72–81) | INNQFLPYPY | ACE-inhibitory |
| κ-casein (46–51) | YIPIQY | ACE-inhibitory |
a angiotensin-converting-enzyme inhibitory (ACE-inhibitory).